EPO tightens up on strict European amendment practice

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO tightens up on strict European amendment practice

Sponsored by

inspicos-400px recrop.jpg
copyright protection of intellectual

Szonja Szenczi-Molnár of Inspicos explains why patent applicants should clearly explain the alternatives and possible combinations concerning claims when drafting description text, in light of a ruling on the allowability of amendments

Under existing EPO practice, an amendment that introduces subject matter that extends beyond the content of the application as filed is unallowable, if the change results in the skilled person being presented with information that is not directly and unambiguously derivable from the content of the application as filed.

A decision by an EPO technical board of appeal (T 1137/21) in June 2023 relates to the allowability of amendments. Claim 1 of the main request was based on claims 1, 4, 9, 11, 13, and 17 as originally filed. The appellant (the patent proprietor) argued that the examples fell under the wording of the claim and that claim 1 did not present the skilled person with new information.

The board of appeal disagreed.

Claim 1 was found to be the result of multiple selections of very specific combinations of features present in different dependent claims, made from among numerous possibilities, having varying degrees of preference. No passage of the original application disclosed the features of claim 1 in combination. While the examples fell under claim 1 of the main request, they were under the most preferred options of the various parameters and ranges, and thus were not sufficient as pointers to the specific selections of claim 1.

Claim 1 did not relate to converging alternatives (T 1621/16) either, due to the lack of pointers. Additionally, some amendments were found to be an arbitrary combination of end points.

Therefore, when drafting patent applications, it is recommended that the description text clearly explains the alternatives and their possible combinations, or at least contains pointers to allow the combination of the less-preferred embodiments, if relevant, in a clear and unambiguous manner.

more from across site and SHARED ros bottom lb

More from across our site

Richard Quatrano, counsel at Olshan Frome Wolosky, shares why technology M&A buyers and sellers must verify written IP assignments, as broken ownership chains can undermine valuation, deal terms, and closing certainty
Appointment of AI and copyright expert Anna Naydonov, as well as another partner from Orrick, shows how firms can attract top litigators through leveraging the power of their existing teams
K&L Gates and Baker Botts have recruited leading patent practitioners from Wende IP and EIP, respectively, as they seek to strengthen European patent litigation capabilities
The departure of a large chunk of Spruson & Ferguson's legacy leadership could have destabilised the firm, but it's fighting back with strategic hires and promotions
By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
This year’s IP STARS Americas rankings reveal that firms are expanding their capabilities, particularly in trade secrets and life sciences
Law firms’ expanding IP capabilities are driving broader industry recognition across a wider range of practice areas
As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC
The firm has added two leading damages specialists as it expands beyond technical analysis and deepens its role in the economics of IP litigation
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
Gift this article